Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinwanhong Pharmaceutical, also referred to as Jingwanhong, operates as one of the key industrial production enterprises under Tianjin Pharmaceutical Holdings Co., Ltd. ("Tianjin Pharma"), a major Chinese pharmaceutical conglomerate. The company contributes to the group's broad portfolio of over 1,300 product categories and participates in both manufacturing and commercialization activities within China[3]. Specific clinical results or pipeline details for Jinwanhong are not publicly detailed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinwanhong Pharmaceutical.